Ignacio G. Camarillo
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
83
Citations
1,111
Est. group size
~3
Recurring co-author estimate
Active years
38
Publishing since 1989
Ignacio G. Camarillo's research focuses on breast cancer, particularly using electrical pulses (electroporation) combined with drugs like metformin, cisplatin, and natural compounds (curcumin, resveratrol, tomato extracts) to improve cancer cell treatment. The work also explores obesity-related signaling pathways (leptin, STAT3) linked to breast cancer progression, and includes engineering-oriented studies on optimizing electroporation devices and electric field uniformity for these experiments.
Publication output has fluctuated over the past decade with peaks in 2019 and 2023, and appears to be maintaining a steady but modest pace of activity in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Conductivity Uncertainty Impact on the Assessment of Efficacy in Electroporation Experiments
IEEE Access · 2026
- Investigations of potential therapeutic targets from high-throughput, label-free, quantitative proteomic studies in MDA-MB-468 cells treated with metformin and electrical pulses
Bioelectrochemistry · 2025
- Round Well Inset for Uniform Electric Field Distribution in Electroporation Applications
Bioengineering · 2025
- Potential Therapeutic Targets from High-Throughput, Label-Free, Quantitative Proteomic Studies in Mda-Mb-468 Cells Treated with Metformin and Electrical Pulses
SSRN Electronic Journal · 2025
- Efficacy of metformin and electrical pulses in breast cancer MDA-MB-231 cells
Exploration of Targeted Anti-tumor Therapy · 2024
- High-Intensity Pulses Modulate Key Cellular Processes of MDA-MD-468 Human Triple-Negative Breast Cancer Cells Treated With Metformin
2024
- Efficacy of electrical pulse mediated tomato lipophilic extract on human breast cancer cell
Journal of Cancer Research and Therapeutics · 2023
- Supplementary Tables S1-S6 from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Supplementary Methods from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Supplementary Figures S1-S5 from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Supplementary Methods from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Supplementary Figures S1-S5 from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Supplementary Tables S1-S6 from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Data from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Data from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression
2023
- Bioelectrochemistry×4
- Scientific Reports×3
- Applied Biochemistry and Biotechnology×3
- Exploration of Targeted Anti-tumor Therapy×2
- Book Publisher International (a part of SCIENCEDOMAIN International)×2
- Raji Sundararajan
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- R. P. Joshi
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Nese Basaran-Akgul
Biochemistry, Genetics and Molecular Biology · Indiana University
- Dharmendra K. Mishra
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Chaminda P. Samaranayake
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile